| Application number | Title of the application | Filing Date | Status |
|---|
Array
(
[id] => 8323511
[patent_doc_number] => 20120195927
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-08-02
[patent_title] => 'GM-NEGATIVE EHV-MUTANTS WITHOUT HETEROLOGOUS ELEMENTS'
[patent_app_type] => utility
[patent_app_number] => 13/446558
[patent_app_country] => US
[patent_app_date] => 2012-04-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 13312
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13446558
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/446558 | gM-negative EHV-mutants without heterologous elements | Apr 12, 2012 | Issued |
Array
(
[id] => 17163165
[patent_doc_number] => 11149254
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-10-19
[patent_title] => Clonal strains of attenuated vaccinia viruses and methods of use thereof
[patent_app_type] => utility
[patent_app_number] => 13/506369
[patent_app_country] => US
[patent_app_date] => 2012-04-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 116568
[patent_no_of_claims] => 65
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 37
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13506369
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/506369 | Clonal strains of attenuated vaccinia viruses and methods of use thereof | Apr 12, 2012 | Issued |
Array
(
[id] => 9094324
[patent_doc_number] => 20130273635
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-10-17
[patent_title] => 'BACTERIOPHAGE KILLING PSEUDOMONAS AERUGINOSA AND STAPHYLOCOCCUS AUREUS'
[patent_app_type] => utility
[patent_app_number] => 13/445564
[patent_app_country] => US
[patent_app_date] => 2012-04-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 4829
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13445564
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/445564 | BACTERIOPHAGE KILLING PSEUDOMONAS AERUGINOSA AND STAPHYLOCOCCUS AUREUS | Apr 11, 2012 | Abandoned |
Array
(
[id] => 8685022
[patent_doc_number] => 20130053306
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-02-28
[patent_title] => 'USE OF HISTONES FOR THE EARLY DIAGNOSIS AND/OR PREVENTIVE THERAPY OF VIRALLY-INFECTED LIVING CELLS AND A BIOCHIP FOR CARRYING OUT SAID DIAGNOSIS'
[patent_app_type] => utility
[patent_app_number] => 13/436788
[patent_app_country] => US
[patent_app_date] => 2012-03-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 3122
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13436788
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/436788 | USE OF HISTONES FOR THE EARLY DIAGNOSIS AND/OR PREVENTIVE THERAPY OF VIRALLY-INFECTED LIVING CELLS AND A BIOCHIP FOR CARRYING OUT SAID DIAGNOSIS | Mar 29, 2012 | Abandoned |
Array
(
[id] => 9280337
[patent_doc_number] => 20140030306
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-01-30
[patent_title] => 'METHODS AND COMPOSITIONS FOR REMEDIATING MICROBIAL INDUCED CORROSION AND ENVIRONMENTAL DAMAGE, AND FOR IMPROVING WASTEWATER TREATMENT PROCESSES'
[patent_app_type] => utility
[patent_app_number] => 14/008942
[patent_app_country] => US
[patent_app_date] => 2012-03-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 24694
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14008942
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/008942 | METHODS AND COMPOSITIONS FOR REMEDIATING MICROBIAL INDUCED CORROSION AND ENVIRONMENTAL DAMAGE, AND FOR IMPROVING WASTEWATER TREATMENT PROCESSES | Mar 28, 2012 | Abandoned |
Array
(
[id] => 10587895
[patent_doc_number] => 09309498
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-04-12
[patent_title] => 'Bacteriophage having bactericidal activity with respect to Actinobacillus pleuropneumoniae'
[patent_app_type] => utility
[patent_app_number] => 14/349899
[patent_app_country] => US
[patent_app_date] => 2012-03-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 2235
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 41
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14349899
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/349899 | Bacteriophage having bactericidal activity with respect to Actinobacillus pleuropneumoniae | Mar 21, 2012 | Issued |
Array
(
[id] => 8289277
[patent_doc_number] => 20120177609
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-07-12
[patent_title] => 'METHOD FOR USING LIBERATED DORMANT BACTERIOPHASE AND ENVIRONMENTAL STRESS TO REDUCE INFECTIOUS BACTERIA'
[patent_app_type] => utility
[patent_app_number] => 13/425555
[patent_app_country] => US
[patent_app_date] => 2012-03-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 4548
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13425555
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/425555 | METHOD FOR USING LIBERATED DORMANT BACTERIOPHASE AND ENVIRONMENTAL STRESS TO REDUCE INFECTIOUS BACTERIA | Mar 20, 2012 | Abandoned |
Array
(
[id] => 9232355
[patent_doc_number] => 08597657
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-12-03
[patent_title] => 'Mutated env sequence involved in the modulation of the immunosuppressive effect of viral proteins'
[patent_app_type] => utility
[patent_app_number] => 13/399208
[patent_app_country] => US
[patent_app_date] => 2012-02-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 38
[patent_no_of_words] => 24188
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 10
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13399208
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/399208 | Mutated env sequence involved in the modulation of the immunosuppressive effect of viral proteins | Feb 16, 2012 | Issued |
Array
(
[id] => 8452807
[patent_doc_number] => 20120263754
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-10-18
[patent_title] => 'Methods for Enhancing Immunogen Specific Immune Responses by Vectored Vaccines'
[patent_app_type] => utility
[patent_app_number] => 13/397216
[patent_app_country] => US
[patent_app_date] => 2012-02-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 35397
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13397216
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/397216 | Methods for Enhancing Immunogen Specific Immune Responses by Vectored Vaccines | Feb 14, 2012 | Abandoned |
Array
(
[id] => 10869835
[patent_doc_number] => 08895027
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-11-25
[patent_title] => 'Recombinant feline leukemia virus vaccine containing optimized feline leukemia virus envelope gene'
[patent_app_type] => utility
[patent_app_number] => 13/364993
[patent_app_country] => US
[patent_app_date] => 2012-02-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 56
[patent_figures_cnt] => 58
[patent_no_of_words] => 19317
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 103
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13364993
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/364993 | Recombinant feline leukemia virus vaccine containing optimized feline leukemia virus envelope gene | Feb 1, 2012 | Issued |
Array
(
[id] => 8138455
[patent_doc_number] => 20120093777
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-04-19
[patent_title] => 'COMPOSITIONS COMPRISING VIRUSES AND METHODS FOR CONCENTRATING VIRUS PREPARATIONS'
[patent_app_type] => utility
[patent_app_number] => 13/334403
[patent_app_country] => US
[patent_app_date] => 2011-12-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8013
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0093/20120093777.pdf
[firstpage_image] =>[orig_patent_app_number] => 13334403
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/334403 | COMPOSITIONS COMPRISING VIRUSES AND METHODS FOR CONCENTRATING VIRUS PREPARATIONS | Dec 21, 2011 | Abandoned |
Array
(
[id] => 9232626
[patent_doc_number] => 08597928
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-12-03
[patent_title] => 'Bacteriophage of the siphoviridae family and antibacterial compositions comprising the same'
[patent_app_type] => utility
[patent_app_number] => 13/331639
[patent_app_country] => US
[patent_app_date] => 2011-12-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 9
[patent_no_of_words] => 11558
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 37
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13331639
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/331639 | Bacteriophage of the siphoviridae family and antibacterial compositions comprising the same | Dec 19, 2011 | Issued |
Array
(
[id] => 10966966
[patent_doc_number] => 20140369998
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-12-18
[patent_title] => 'Biomarkers for Tuberculosis and HIV/AIDS'
[patent_app_type] => utility
[patent_app_number] => 13/992458
[patent_app_country] => US
[patent_app_date] => 2011-12-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 8658
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13992458
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/992458 | Biomarkers for Tuberculosis and HIV/AIDS | Dec 8, 2011 | Abandoned |
Array
(
[id] => 9205327
[patent_doc_number] => 20140004504
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-01-02
[patent_title] => 'COMPOSITIONS AND METHODS FOR THE DETECTION AND ANALYSIS OF AFRICAN SWINE FEVER VIRUS'
[patent_app_type] => utility
[patent_app_number] => 13/993028
[patent_app_country] => US
[patent_app_date] => 2011-12-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 11242
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13993028
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/993028 | COMPOSITIONS AND METHODS FOR THE DETECTION AND ANALYSIS OF AFRICAN SWINE FEVER VIRUS | Dec 8, 2011 | Abandoned |
Array
(
[id] => 8197052
[patent_doc_number] => 20120121597
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-05-17
[patent_title] => 'FUSION PROTEINS FOR HIV THERAPY'
[patent_app_type] => utility
[patent_app_number] => 13/294652
[patent_app_country] => US
[patent_app_date] => 2011-11-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 28
[patent_figures_cnt] => 28
[patent_no_of_words] => 12436
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0121/20120121597.pdf
[firstpage_image] =>[orig_patent_app_number] => 13294652
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/294652 | Fusion antibodies for HIV therapy | Nov 10, 2011 | Issued |
Array
(
[id] => 8908983
[patent_doc_number] => 08481041
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-07-09
[patent_title] => 'Dock-and-lock (DNL) constructs for human immunodeficiency virus (HIV) therapy'
[patent_app_type] => utility
[patent_app_number] => 13/288202
[patent_app_country] => US
[patent_app_date] => 2011-11-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 21
[patent_no_of_words] => 32426
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 63
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13288202
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/288202 | Dock-and-lock (DNL) constructs for human immunodeficiency virus (HIV) therapy | Nov 2, 2011 | Issued |
Array
(
[id] => 9134932
[patent_doc_number] => 20130295647
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-11-07
[patent_title] => 'METHOD OF PRODUCING BACTERIOPHAGE PREPARATIONS COMPRISING PURIFICATION USING AFFINITY CHROMATOGRAPHY'
[patent_app_type] => utility
[patent_app_number] => 13/881795
[patent_app_country] => US
[patent_app_date] => 2011-10-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 3509
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13881795
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/881795 | Method of producing bacteriophage preparations comprising purification using affinity chromatography | Oct 27, 2011 | Issued |
Array
(
[id] => 9561141
[patent_doc_number] => 20140178854
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-06-26
[patent_title] => 'ANTISERA ASSAYS FOR MLV RELATED VIRUSES IN HUMANS AND OTHER MAMMALS'
[patent_app_type] => utility
[patent_app_number] => 13/882713
[patent_app_country] => US
[patent_app_date] => 2011-10-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 46
[patent_figures_cnt] => 46
[patent_no_of_words] => 20067
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13882713
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/882713 | ANTISERA ASSAYS FOR MLV RELATED VIRUSES IN HUMANS AND OTHER MAMMALS | Oct 27, 2011 | Abandoned |
Array
(
[id] => 8323509
[patent_doc_number] => 20120195928
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-08-02
[patent_title] => 'VACCINES AND METHODS FOR USING THE SAME'
[patent_app_type] => utility
[patent_app_number] => 13/284824
[patent_app_country] => US
[patent_app_date] => 2011-10-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 11556
[patent_no_of_claims] => 40
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13284824
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/284824 | Compositions for and methods of inducing mucosal immune responses | Oct 27, 2011 | Issued |
Array
(
[id] => 10018503
[patent_doc_number] => 09060972
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-06-23
[patent_title] => 'Recombinant hemagglutinin protein of influenza virus and vaccine containing the same'
[patent_app_type] => utility
[patent_app_number] => 13/279253
[patent_app_country] => US
[patent_app_date] => 2011-10-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 7379
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 61
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13279253
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/279253 | Recombinant hemagglutinin protein of influenza virus and vaccine containing the same | Oct 21, 2011 | Issued |